PANERIS Project Concludes: A Lasting Impact on European Neuroscience
As the PANERIS project comes to an end, we are proud to reflect on a journey marked by collaboration, knowledge exchange, and meaningful impact across the European neuroscience community.
Over the course of the project, PANERIS has brought together partners from Lithuania, Poland, Portugal, and Spain, creating a strong and sustainable network of researchers. Through joint activities, training initiatives, and scientific exchange, the project has contributed to strengthening research capacity, fostering international collaboration, and supporting the development of early-career researchers.
Key achievements of PANERIS include the establishment of new research collaborations, the integration of partners into European research and innovation networks, and the creation of opportunities that will continue beyond the lifetime of the project. Activities such as short-term scientific missions, summer and winter schools, and outreach initiatives have played a vital role in empowering researchers and connecting science with society.
Importantly, PANERIS has demonstrated that building successful scientific synergies begins with people. By fostering trust, exchange, and early collaboration between researchers, the project has laid the groundwork for future initiatives and long-term partnerships in neuroscience.
To mark the conclusion of the project, we invite you to watch our short video, highlighting the key achievements, experiences, and impact of PANERIS.
As PANERIS comes to a close, its legacy continues through the collaborations, knowledge, and networks it has created. We thank all partners, researchers, and participants who have contributed to this journey and look forward to seeing how these connections will shape the future of neuroscience research in Europe.
Acknowledgments
The PANERIS project and all related activities were implemented through the close collaboration of all consortium partners: the Gulbenkian Institute for Molecular Medicine (iMM), the Fundació de Recerca Clínic Barcelona – Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Vilnius University (VU), and the Maj Institute of Pharmacology of the Polish Academy of Sciences (IP PAS).
The opinions and views expressed are solely those of their author(s) and do not necessarily reflect those of the European Union or of the European Research Executive Agency (REA). Neither the European Union nor the REA can be held responsible for them.
